Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sanofi Halves Price of Cancer Drug Zaltrap After Sloan-Kettering Rejection
Sanofi Halves Price of Cancer Drug Zaltrap After Sloan-Kettering Rejection
Sanofi Halves Price of Cancer Drug Zaltrap After Sloan-Kettering Rejection
Submitted by
admin
on November 8, 2012 - 10:22pm
Source:
NY Times, NY
News Tags:
drug pricing
Sanofi
Sloan Kettering
colon cancer
Zaltrap
Headline:
Sanofi Halves Price of Cancer Drug Zaltrap After Sloan-Kettering Rejection
Do Not Allow Advertisers to Use My Personal information
